J0637 – Injection, caspofungin acetate, 5 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ0637
- Long description
- Injection, caspofungin acetate, 5 mg
- Short description
- Caspofungin acetate
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- Added
- January 1, 2003
- Last change
- January 1, 2024 – No change
Frequently asked questions
What is HCPCS code J0637?
J0637 is a HCPCS Level II code for injection, caspofungin acetate, 5 mg.
Does Medicare cover J0637?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J0613 – Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg
- J0614 – Injection, treosulfan, 50 mg
- J0615 – Calcium acetate, oral, 23 mg (for esrd on dialysis)
- J0616 – Injection, metoprolol tartrate, 1 mg
- J0618 – Injection, calcium chloride, 2 mg
- J0620 – Injection, calcium glycerophosphate and calcium lactate, per 10 ml
- J0630 – Injection, calcitonin salmon, up to 400 units
- J0636 – Injection, calcitriol, 0.1 mcg
- J0638 – Injection, canakinumab, 1 mg
- J0640 – Injection, leucovorin calcium, per 50 mg
- J0641 – Injection, levoleucovorin, not otherwise specified, 0.5 mg
- J0642 – Injection, levoleucovorin (khapzory), 0.5 mg
- J0643 – Injection, leucovorin calcium, not otherwise specified, 1 mg
- J0644 – Injection, leucovorin calcium (avyxa), 1 mg
- J0650 – Injection, levothyroxine sodium, not otherwise specified, 10 mcg
- J0651 – Injection, levothyroxine sodium (fresenius kabi), not therapeutically equivalent to j0650, 10 mcg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.